MedPath

Effect of Virtual Reality Therapy on Dysphagia in Wallenberg Syndrome

Not Applicable
Recruiting
Conditions
Wallenberg Syndrome
Interventions
Device: Virtual Reality Therapy
Behavioral: Conventional dysphagia treatment
Registration Number
NCT06286020
Lead Sponsor
Zeng Changhao
Brief Summary

The goal of this clinical trial is to learn about on dysphagia in wallenberg syndrome. The main questions it aims to answer are:

the efficacy of Virtual Reality Therapy in the rehabilitation of patients with dysphagia in Wallenberg syndrome.

Participants received conventional dysphagia treatment and Virtual Reality Therapy once a day for 14 days. Researchers compared the control group to see the effect and mechanism of Virtual Reality Therapy.

Detailed Description

Virtual Reality technology has revolutionized various fields, and its application in rehabilitation medicine is particularly noteworthy. Virtual Reality provides immersive environments that simulate real-life situations, making it an invaluable tool in the rehabilitation process.

The goal of this clinical trial is to learn about on dysphagia in wallenberg syndrome. The main questions it aims to answer are:

the efficacy of Virtual Reality Therapy in the rehabilitation of patients with dysphagia in Wallenberg syndrome.

Participants received conventional dysphagia treatment and Virtual Reality Therapy once a day for 14 days. Researchers compared the control group to see the effect and mechanism of Virtual Reality Therapy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • age ranged from 18-85 years and right-handed;
  • first onset, vital signs stable and conscious;
  • the dysphagia confirmed by videofluoroscopic swallowing study;
  • no cognitive impairment, the mini-mental state examination score: >17 for those with an illiterate education, >20 for those with an elementary education, and >24 for those with a secondary education and above;
  • cranial integrity without craniotomy and/or craniectomy;
  • patient and/or his/her relative agrees and signs written informed consent.
Exclusion Criteria
  • combined ischemic foci at other sites;
  • presence of organic swallowing dysfunction or pre-existing dysphagia due to Parkinson's disease, dementia, and others;
  • severe cardiac, pulmonary, hepatic, and renal insufficiency and vital organ failure;
  • infected or broken skin on the head;
  • poorly controlled epilepsy;
  • poor patient compliance.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The experimental groupConventional dysphagia treatmentconventional dysphagia treatment and Virtual Reality Therapy are provided
The experimental groupVirtual Reality Therapyconventional dysphagia treatment and Virtual Reality Therapy are provided
The control groupConventional dysphagia treatmentconventional dysphagia treatment is provided
Primary Outcome Measures
NameTimeMethod
standardized swallowing assessmentday 1 and day 14

The standardized swallowing assessment was used to assess the improvement of overall swallowing function, it has a maximum score of 46 and a minimum score of 18, with lower scores indicating better swallowing function.

Secondary Outcome Measures
NameTimeMethod
Rosenbek penetration-aspiration scaleday 1 and day 14

The highest Rosenbek penetration-aspiration scale score is 8 and the lowest is 1 (1 = no entry of material into the airway; 2 - 5 = penetration of material past the mouse into the supraglottic space and traveling as far as the true vocal folds; 6 - 8 = tracheal aspiration of material below the true vocal folds).

swallowing-quality of lifeday 1 and day 14

Swallowing-quality of life has a score range of 44 - 220, with lower scores indicating poorer swallowing function and poorer quality of life.

Murray secretion scaleday 1 and day 14

The severity of Murray secretion scale was measured using a grade of 0-3, patients without obvious saliva accumulation are scored as Murray secretion scale grade 0, whereas patients who had secretions in the laryngeal vestibule at the start of the exam were assigned grade 3.

Trial Locations

Locations (1)

Xinzhu Rehabilitation Hospital

🇨🇳

Xinzhu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath